Skip to main content
. 2000 Apr;11(4):1357–1367. doi: 10.1091/mbc.11.4.1357

Table 1.

In vivo tumorigenicity of HMT-3522 cell lines

Cell type No. of injection sitesa No. of sites with tumorsb Mean tumor size (mm3) ± SE (n)
S1 32 0 0 (0)
T4-2 32 28 250  ± 80 (28)
T4-2 + vector 32 28 265  ± 95 (28)
T4-2 + AZU-1 32 4 38  ± 19 (4)
a

Two injection sites per mouse; 16 mice in each group. 

b

Lump >10 mm3